Evaluation of Kashoos syrup on clinical and paraclinical symptoms of patients with Non-Alcoholic Steatohepatitis (NASH)

Clinical trial for evaluation of Kashoos herbal syrup on clinical and paraclinical symptoms (enzymes and liver sonography) of patients of 25 to 50 years old with Non-Alcoholic Steatohepatitis (NASH)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014120320197N1

Enrollment

Registered

2015-12-14

Start date

2015-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic steatohepatitis (NASH). One of specified inflammatory liver diseases

Interventions

Consumption of ten ml of Kashoos herbal syrup three meals daily, half an hour before the main meal food with half cup of boiling water for 3 months.

Treatment - Drugs

Consumption of ten ml of Kashoos herbal syrup three meals daily, half an hour before the main meal food with half cup of boiling water for 3 months

Eligibility

Sex/Gender

All

Age

25 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: non presence of CAH; hepatotoxic drug; alcoholic drinks; uncontrolled hypothyroidism; elevation of LFT 6 months before exam; presence of fatty liver in sonography; non using herbal or chemical drugs effective on fatty liver. Exclusion criteria: absence in 2 consecutive visits; demonstration of any unexpected medical side effects (refereed to Liver Clinic of Traditional Medicine).

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Liver enzymes (ALT, AST). Timepoint: Monthly. Method of measurement: Laboratory.;Degree of fatty liver in sonography. Timepoint: Before and after intervention. Method of measurement: Ultrasound.;Abdominal circumference at three points (around the navel, above and below the navel). Timepoint: Monthly. Method of measurement: Meter.;Blood pressure in three positions (lying, sitting and standing). Timepoint: Monthly. Method of measurement: Mercury sphygmomanometer.	—

Measure

Time frame

Liver enzymes (ALT, AST). Timepoint: Monthly. Method of measurement: Laboratory.;Degree of fatty liver in sonography. Timepoint: Before and after intervention. Method of measurement: Ultrasound.;Abdominal circumference at three points (around the navel, above and below the navel). Timepoint: Monthly. Method of measurement: Meter.;Blood pressure in three positions (lying, sitting and standing). Timepoint: Monthly. Method of measurement: Mercury sphygmomanometer.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. monirosadat Roohollahi

Traditional Medicine College of Mashhad University of Medical Sciences

roohollahi@razi.tums.ac.ir; asadi.mj@gmail.com+98 21 7720 3531

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026